Table 5.

Outcome of patients

Total number	SFSS n (%) 20 (100)	-	No SFSS n (%) 154 (100)	-	P value
Overall mortality	15 (75)	Grade	62 (40.3)	Grade	0.003
Cause of mortality and their Dindo-Clavien score
Sepsis from causes other than SFSS	0	-	19 (30.6)	V	0
SFSS (sepsis, graft failure, DIC, renal failure, ARDS, MOF)	13 (86.7)	V	0	-
MOF from causes other than SFSS	0	-	11 (17.7)	V
Post-operative bleeding	2 (13.3)	V	10 (16.1)	V
Intra-operative bleeding	0	-	8 (12.9)	V
PVT	0	-	4 (6.4)	V
Renal impairment from causes other than SFSS	0	-	2 (3.2)	V
Metastatic cholangiocarcinoma	0	-	2 (3.2)	V
Early graft dysfunction from causes other than SFSS	0	-	2 (3.2)	V
HCC recurrence	0	-	2 (3.2)	V
Ischemic reperfusion injury	0	-	1 (1.6)	V
HAT	0	-	1 (1.6)	V
6-mo survival	6 (30)	-	108 (70.1)	-	0.000
1-yr survival	6 (30)	-	101 (65.6)	-	0.002
3-yr survival	5 (25)	-	95 (61.7)	-	0.002
5-yr survival	5 (25)	-	94 (61)	-	0.002
7-yr survival	5 (25)	-	92 (59.7)	-	0.003
10-yr survival	5 (25)	-	92 (59.7)	-	0.003
Survival per months (mean ± SD)	16.3 ± 28.9	-	39.9 ± 34.3	-	0.002
Graft survival	4 (20)		89 (57.8)		0.001
Graft survival per months (mean ± SD)	16.2 ± 28.9		39.7 ± 34.3		0.003

SFSS: Small for size syndrome; DIC: Disseminated intravascular coagulation; ARDS: Adult respiratory distress syndrome; MOF: Multi organ failure; PVT: Portal vein thrombosis; HCC: Hepatocellular carcinoma; HAT: Hepatic artery thrombosis.